Arkema: 2nd Quarter 2013 Results Solid Performance in a Contrasted Economic Environment *€1,629million sales, 1.7% down at constant exchange rate and scope of business *Volumes +3.5% up, mainly supported by Coating Solutions segment *€273million EBITDA and 16.8% EBITDA margin *High Performance Materials result significantly up versus 1^st quarter 2013 but down versus high basis of comparison of 2012 *Strong margin in Industrial Specialties despite adverse impact of weather conditions on fluorogases *Resilient performance of Coating Solutions but mixed results between the regions *€112million net income Group share, i.e. 7% of sales Business Wire COLOMBES, France -- August 1, 2013 Regulatory News: The Board of Directors of Arkema (Paris:AKE) met on July 31^st 2013 to close the condensed consolidated accounts of Arkema for 1^st half 2013. At the end of the meeting, Thierry Le Hénaff, Chairman and CEO, stated: «In 2^nd quarter, Arkema confirmed the strength of its results in a less favorable economic environment than last year which also shows strong disparities from one geographic region to another. Market conditions in Europe are challenging, in particular in France where growth prospects have deteriorated since the end of last year and where the Group continues to consider ways to improve its productivity. Nevertheless, the Group benefited from its balanced geographic presence worldwide, its growing footprint in North America, and its diversified end-markets and continued to benefit from its positioning in high added value specialty businesses. The Group actively reinforced its assets as shown by the capacity extension of its acrylic production capacities in North America in the 2^nd quarter, and the construction of its Thiochemicals platform in Malaysia. » 2^ND QUARTER 2013 KEY FIGURES (In millions of euros) 2^nd quarter 2^nd quarter Variation 2012 2013 Sales 1,719 1,629 -5.2% EBITDA 306 273 -10.8% EBITDA margin 17.8% 16.8% High Performance 19.1% 19.5% Materials Industrial Specialties 22.1% 21.1% Coating Solutions 14.4% 14.0% Recurring operating 229 195 -14.8% income Non-recurring items (25) (13) n.a. Adjusted net income* 151 124 -17.9% Net income – Group share (12) 112 n.a. Diluted adjusted net 2.40 1.96 -18.3% income per share* (in €) * For 2^nd quarter 2012, adjusted net income of continuing operations (excluding impact of vinyl activities sold beginning of July 2012). 2^ND QUARTER 2013 PERFORMANCE Sales in 2^nd quarter 2013 stood at €1,629million against €1,719million in 2^nd quarter 2012. The +3.5% growth in volumes was mainly supported by the Coating Solutions segment which benefited from an increasing presence in North America where the housing market has been gradually improving. The -5.2% price / product mix effect reflected in particular the decrease in certain raw material costs and a different product mix than in 2012 in High Performance Materials. The -2.3% scope of business effect related to the divestment of the tin stabilizer business finalized on 1^st October 2012. The -1.2% translation effect mostly corresponded to the slight strengthening of the euro versus the US dollar. In an economic environment that was less favorable than last year, EBITDA, as expected, stood at €273million in-between the high reference of the 2^nd quarter 2012 (€306 million) and the 1^st quarter of 2013 (€234 million), thereby confirming the strength of the portfolio of the Group’s specialty activities and its balanced geographic presence. The performance of High Performance Materials improved compared to 1^stquarter 2013, but was still below last year due to ongoing weak demand in the photovoltaic market and to delays in certain oil and gas projects. Industrial Specialties continued to deliver a high level of performance despite weaker fluorogas business versus last year. Coating Solutions reported a strong and stable result compared with last year, with improving conditions in North America offsetting the more challenging market conditions in decorative paints and construction in Europe. Finally, EBITDA was negatively impacted by the strengthening of euro versus US dollar and by the drop of the yen which resulted in a negative transaction effect. EBITDA margin maintained a very good level at 16.8% and once again stood among the highest in the industry. Recurring operating income stood at €195million against €229million in 2^nd quarter 2012, following deduction of €78million depreciation and amortization, virtually stable compared to last year. Non-recurring items stood at -€13 million against -€25million in 2^nd quarter 2012. They included in particular some restructuring charges. In 2^nd quarter 2012, these items mostly included the impact of the shortage in the supply of CDT (the raw material for polyamide 12) amounting to -€16million in total as well as various charges related to divestment and acquisition operations. Financial result stood at -€13million, close to 2^nd quarter 2012 (-€14million). Income taxes amounted to €57million, i.e. 29.2% of recurring operating income. They included a €3million tax due on the dividend paid in June 2013. Excluding this tax, the tax rate would stand at 27.7% of the recurring operating income, reflecting the geographic spread of the results with a significant part of the Group’s results achieved in North America and a smaller part in Europe. Net income Group share stood at €112million against a -€12million loss in 2^nd quarter 2012. SEGMENT PERFORMANCE IN 2^ND QUARTER 2013 HIGH PERFORMANCE MATÉRIALS High Performance Materials sales reached €477million against €572million in 2^nd quarter 2012. The divestment of the tin stabilizer activities represented nearly half of the sales decrease. The negative price effect mostly reflected the lower raw material costs and a different product mix than in 2012. Finally, volumes were slightly down compared to last year. With €93million EBITDA and a 19.5% EBITDA margin, the performance of the segment showed a significant improvement compared to 1^st quarter 2013 (€70million EBITDA) while being below the 2^nd quarter 2012 (€109million EBITDA). The decrease compared to 2012 resulted mainly from weaker demand in photovoltaic market and by delays in some oil and gas projects already mentioned in the 1^st quarter 2013. Specialty Polyamides delivered an excellent performance which reflected the innovation momentum in the field of lightweight materials and a stronger seasonality than expected. The Organic Peroxides EBITDA margin benefited from its reshaped portfolio of businesses following the divestment of the tin stabilizer business. INDUSTRIAL SPECIALTIES With an EBITDA margin above 21%, the performance of Industrial Specialties segment was maintained at a very high level despite fluorogas business being down versus last year on adverse weather conditions in Europe and competitive pressure in China and Europe on certain gases. Sales reached €540million against €566million in 2^nd quarter 2012. EBITDA stood at €114million reflecting the ongoing favorable environment in the United States where the Group has developed over the years a strong industrial presence. The solid results of Thiochemicals were supported by refining and petrochemicals markets in the US. In PMMA, performances in North America and in Europe were mixed reflecting different momentum in the automotive and construction markets by region. Finally, Hydrogen Peroxide performance remained stable overall. COATING SOLUTIONS Coating Solutions sales reached €602million against €575million in 2^nd quarter 2012. This 4.7% increase reflected mostly higher volumes in North America, supported by a gradual improvement in demand in the residential housing market and the startup of the acrylic acid production capacity extension in Clear Lake (Texas). EBITDA stood at €84million and EBITDA margin at 14.0% against €83million and 14.4% respectively in 2^nd quarter 2012. Acrylics benefited from volumes up year-on-year while unit margins were lower than their high level of the 2^nd quarter 2012 which was then supported by sharply decreasing propylene prices. Market conditions in Coating Resins remained mixed. Demand grew in North America, but remained lackluster in Europe where weather conditions remained adverse in the quarter. Finally, the performance of Sartomer and Coatex remained resilient sustained by new product development. HIGHLIGHTS SINCE 1^ST APRIL 2013 Organic growth projects On 5^th June 2013, Arkema announced the startup of the acrylic acid capacity extension at its Clear Lake site in the United States. This project, which raises the site’s capacity to some 270KT per year, represents the main part of the US$110M investment plan announced in November 2010. On 18^th June 2013, Arkema announced a 15% increase in its bis-peroxide global capacities at both its Spinetta (Italy) and Franklin (Virginia, United States) sites. These new capacities, already operational, represent the first stage of a program designed to increase bis-peroxyde global capacity by 30% by end of 2014. These will help meet strong demand in the synthetic rubber industry for crosslinking agents, in particular in Asia, while also supporting recent developments. Acquisitions Arkema completed two acquisitions in line with its strategy in High Performance Materials: *Securing access to its strategic raw materials: On 11^th April 2013, Arkema signed an agreement with Indian company Jayant Agro, one of the world leading producers of castor oil and derivatives, with a view to acquiring a stake of around 25% in Ihsedu Agrochem, one of its subsidiaries specializing in castor oil production. This operation will provide Arkema with competitive and secure long-term access to this strategic raw material for the manufacture of its biosourced polyamides (PA 10 and PA 11). This project should be finalized in 3^rd quarter 2013. *Speeding up development through innovation: On 3^rd April 2013, Arkema announced its acquisition of a majority stake in AEC Polymers, which produces in particular structural adhesives from methacrylates developed by an Arkema technology. Other highlights On 3^rd July 2013, the Fonds Stratégique de Participation (FSP), a mutual fund set up by four major insurance companies in France – BNP Paribas Cardif, CNP Assurances, Crédit Agricole Assurances through its subsidiary Predica, and Sogécap (Société Générale Group) – in order to promote long-term investment in listed companies, announced that it now owns 6% of Arkema’s share capital. Arkema considers this acquisition of a stake in its share capital as a positive sign showing the confidence of the FSP in the long-term strategy implemented by the Group and in its management. With a prospect of maintaining a long-term investment of at least 6% of Arkema's share capital, the FSP has shared with the Board of Directors its intent to seek the appointment of a representative on the Board of Directors. The Board of Directors will consider favorably this request for the appointment of an independent representative made by the FSP. 1^ST HALF 2013 KEY FIGURES (In millions of euros) 1^st half 1^st half Variation 2012 2013 Sales 3,342 3,192 -4.5% EBITDA 559 507 -9.3% EBITDA margin 16.7% 15.9% High Performance Materials 19.1% 17.6% Industrial Specialties 20.2% 20.2% Coating Solutions 13.9% 13.8% Recurring operating income 409 353 -13.7% Non-recurring items (25) (140) n.a. Adjusted net income* 274 221 -19.3% Net income – Group share 88 82 -6.8% Diluted adjusted net income 4.37 3.49 -20.1% per share* (in €) * For 1^st half 2012, adjusted net income of continuing operations (excluding impact of vinyl activities sold beginning of July 2012). CASH FLOW AND NET DEBT AT 30^TH JUNE 2013 In 2^nd quarter 2013, free cash flow^1 stood at +€44million against -€28million in 2^nd quarter 2012. Over the 1^st half of the year, it stood at -€16million against -€23million in 1^st half 2012. On the first 6 months, this flow included a -€156million variation in working capital related to the traditional increase in sales in the first half of the year. The working capital to sales ratio, however, remained well under control at 17.3%, at the same level as at 30^th June 2012. Capital expenditure reached €174million in the first six months and should accelerate in the 2^nd half of the year, as it is the case each year, to reach €500million for the full year 2013. The Group also paid on 11^th June a €1.80 dividend per share, totaling €113million. Moreover, as part of its commitments previously made regarding Kem One, Arkema cashed out an amount of €75 million in the 2^nd quarter. This amount was already fully booked in the accounts at the end of the 1^st quarter. Net debt stood at €1,150million at 30^th June 2013 (€900million at 31^st December 2012), i.e. 49.6% gearing, close to last year’s level (48.7% at 30^th June 2012). However, the Group confirmed its objective to reduce its gearing to around 40% by the end of the year. ^1 Cash flow from operations and investments, excluding impact of portfolio management and before the impact of cash-outs related to Kem One situation. OUTLOOK Market conditions in the second half of the year should be in the continuity of the first half of the year with a marked contrast by regions and a limited visibility. They should continue to be solid in North America, and challenging but stable in Europe. In Asia, China in particular, growth should remain slower than expected. High Performance Materials should continue to be impacted in the 3^rd quarter by the weakness in photovoltaic market and delays in some oil and gas projects. However, those markets should as expected improve by year end. In this environment, Arkema should achieve in the second half of the year an EBITDA similar to the record level of the 2^nd half of 2012. Compared to 2012, the 3^rd quarter EBITDA should be lower than the high reference of last year and the 4^th quarter stronger. The Group thereby confirms its ability to achieve a strong annual performance in a macro-economic environment that is less favorable than in 2012. The Group, however, will continue to carefully monitor the macro-economic environment developments and will implement the necessary adjustment initiatives if it was to be necessary. The Group continues to implement its focused growth strategy with several progresses and confirms its ambition for 2016 to achieve €8billion sales and 16% EBITDA margin while maintaining gearing below 40%. The 2^nd quarter 2013 results and the outlook are detailed in the presentation “2^nd Quarter 2013 Results and Highlights” available on the website: www.finance.arkema.com. The 1^st Half 2013 Financial Report is also available on the website. FINANCIAL CALENDAR 7^th November 2013 Publication of 3^rd quarter 2013 results A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of €6.4 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands. Disclaimer The information disclosed in this press release may contain forward-looking statements with respect to the financial conditions, results of operations, business and strategy of Arkema. Such statements are based on management’s current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as, among others, changes in raw materials prices, currency fluctuations, implementation pace of cost-reduction projects and changes in general economic and business conditions. Arkema does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect Arkema’s financial results is provided in the documents filed with the French Autorité des marchés financiers. Balance sheet, income statement, cash flow statement, statement of changes in shareholders’ equity and information by business segment included in this press release are extracted from the consolidated financial statements at 30 June 2013 closed by the Board of Directors of Arkema SA on 31 July 2013. Quarterly financial information is not audited. Business segment information is presented in accordance with ARKEMA’s internal reporting system used by the management. The main performance indicators used are as follows: *Operating income: this includes all income and expenses of continuing operations other than financial result, equity in income of affiliates and income taxes; *Other income and expenses: these correspond to a limited number of well-identified non-recurring items of income and expense of a particularly material nature that the Group presents separately in its income statement in order to facilitate understanding of its recurring operational performance. These items of income and expense notably include: *Impairment losses in respect of property, plant and equipment and intangible assets, *Gains or losses on sale of assets, acquisition expenses, badwills and stock valuation adjustments between the fair value on the acquisition date and the replacement value *Certain large restructuring and environmental expenses which would hamper the interpretation of recurring operating income (including substantial modifications to employee benefit plans and the effect of onerous contracts), *Certain expenses related to litigation and claims or major damages, whose nature is not directly related to ordinary operations; *Recurring operating income: this is calculated as the difference between operating income and other income and expenses as previously defined; *Adjusted net income: this corresponds to “Net income – Group share” adjusted for the “Group share” of the following items: *Other income and expenses, after taking account of the tax impact of these items, *Income and expenses from taxation of an exceptional nature, the amount of which is deemed significant, *Net income of discontinued operations; *EBITDA: this corresponds to recurring operating income increased by depreciation and amortization; *Working capital: this corresponds to the difference between inventories, accounts receivable, other receivables and prepaid expenses, income tax receivables and other current financial assets on the one hand and accounts payable, other creditors and accrued liabilities, income tax liabilities and other current financial liabilities on the other hand. These items are classified in current assets and liabilities in the consolidated balance sheet; *Capital employed: this is calculated by aggregating the net carrying amounts of intangible assets, property, plant and equipment, equity affiliate investments and loans, other investments, other non-current assets (excluding deferred tax assets) and working capital; *Recurring investments: these correspond to tangible and intangible investments which exclude a small number of investments of an exceptional nature that the Group presents separately in order to facilitate the analysis of cash generation in its financial communication. These investments characterized by their size or their nature are presented either as non-recurring investments or in acquisitions and divestments; *Net debt: this is the difference between current and non-current debt and cash and cash equivalents. ARKEMA Financial Statements Consolidated financial statements - At the end of June 2013 CONSOLIDATED INCOME STATEMENT 2^nd End of 2^nd End of quarter June 2013 quarter June 2012 2013 2012 (In millions of (non (audited) (non (audited) euros) audited) audited) Sales 1,629 3,192 1,719 3,342 Operating (1,293) (2,549) (1,348) (2,645) expenses Research and development (37) (76) (36) (74) expenses Selling and administrative (104) (214) (106) (214) expenses Recurring 195 353 229 409 operating income Other income and (13) (140) (25) (25) expenses Operating income 182 213 204 384 Equity in income 1 3 3 6 of affiliates Financial result (13) (27) (14) (25) Income taxes (57) (106) (63) (112) Net income of continuing 113 83 130 253 operations Net income of discontinued - - (141) (164) operations Net income 113 83 (11) 89 Of which non-controlling 1 1 1 1 interests Net income - 112 82 (12) 88 Group share Of which continuing 112 82 129 252 operations Of which discontinued - - (141) (164) operations Earnings per share (amount in 1.79 1.31 (0.20) 1.42 euros) Earnings per share of continuing 1.79 1.31 2.08 4.07 operations (amount in euros) Diluted earnings per share 1.77 1.29 (0.20) 1.40 (amount in euros) Diluted earnings per share of continuing 1.77 1.29 2.05 4.02 operations (amount in euros) Depreciation and (78) (154) (77) (150) amortization EBITDA 273 507 306 559 Adjusted net income of 124 221 151 274 continuing operations Adjusted net income per share of continuing 1.98 3.53 2.43 4.42 operations (amount in euros) Diluted adjusted net income per share of continuing 1.96 3.49 2.40 4.37 operations (amount in euros) CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 2^nd End of 2^nd End of quarter June 2013 quarter June 2012 2013 2012 (In millions of (non (audited) (non (audited) euros) audited) audited) Net income 113 83 (11) 89 Hedging 1 (2) 1 (6) adjustments Other items - - - - Deffered taxes on hedging - - - - adjustments and other items Change in translation (37) 1 79 40 adjustments Other recyclable comprehensive income of (36) (1) 80 34 continuing operations Actuarial gains 41 41 (44) (44) and losses Deffered taxes on actuarial (16) (16) 9 9 gains and losses Other non-recyclable comprehensive 25 25 (35) (35) income of continuing operations Other comprehensive income of (11) 24 45 (1) continuing operations Other comprehensive income of - - 1 (5) discontinued operations Total income and expenses recognized (11) 24 46 (6) directly in equity Comprehensive 102 107 35 83 income Of which: non-controlling - 1 2 1 interest Comprehensive income - Group 102 106 33 82 share CONSOLIDATED BALANCE SHEET 30 June 2013 31 December 2012 (audited) (audited) (In millions of euros) ASSETS Intangible assets, net 969 962 Property, plant and equipment, net 1,876 1,852 Equity affiliates : investments and 67 71 loans Other investments 58 36 Deferred tax assets 67 83 Other non-current assets 151 147 TOTAL NON-CURRENT ASSETS 3,188 3,151 Inventories 954 920 Accounts receivable 1,024 920 Other receivables and prepaid 172 147 expenses Income taxes recoverable 27 35 Other current financial assets 3 8 Cash and cash equivalents 299 360 TOTAL CURRENT ASSETS 2,479 2,390 Assets held for sale - - TOTAL ASSETS 5,667 5,541 LIABILITIES AND SHAREHOLDERS' EQUITY Share capital 629 629 Paid-in surplus and retained earnings 1,581 1,587 Treasury shares (12) (16) Translation adjustments 83 82 SHAREHOLDERS' EQUITY - GROUP SHARE 2,281 2,282 Non-controlling interests 36 29 TOTAL SHAREHOLDERS' EQUITY 2,317 2,311 Deferred tax liabilities 43 33 Provisions for pensions and other 392 432 employee benefits Other provisions and non-current 413 446 liabilities Non-current debt 1,068 1,071 TOTAL NON-CURRENT LIABILITIES 1,916 1,982 Accounts payable 739 683 Other creditors and accrued 272 318 liabilities Income taxes payable 40 56 Other current financial liabilities 2 2 Current debt 381 189 TOTAL CURRENT LIABILITIES 1,434 1,248 Liabilities associated with assets - - held for sale TOTAL LIABILITIES AND SHAREHOLDERS' 5,667 5,541 EQUITY CONSOLIDATED CASH FLOW STATEMENT End of June 2013 End of June 2012 (In millions of euros) (audited) (audited) Cash flow - operating activities Net income 83 89 Depreciation, amortization and 155 188 impairment of assets Provisions, valuation allowances and (24) 14 deferred taxes (Gains)/losses on sales of assets (4) (10) Undistributed affiliate equity 6 3 earnings Change in working capital (156) (209) Other changes 4 3 Cash flow from operating activities 64 78 Of which cash flow from operating - (123) activities of discontinued operations Cash flow - investing activities Intangible assets and property, (174) (217) plant, and equipment additions Change in fixed asset payables (25) (32) Acquisitions of operations, net of (10) (243) cash acquired Increase in long-term loans (16) (25) Total expenditures (225) (517) Proceeds from sale of intangible assets and property, plant and 5 13 equipment Change in fixed asset receivables - - Proceeds from sale of operations, net - - of cash sold Proceeds from sale of unconsolidated - - investments Repayment of long-term loans 14 8 Total divestitures 19 21 Cash flow from investing activities (206) (496) Of which cash flow from investing activities from discontinued - (48) operations Cash flow - financing activities Issuance (repayment) of shares and 8 33 other equity Purchase of treasury shares - (13) Dividends paid to parent company (113) (81) shareholders Dividends paid to minority - (1) shareholders Increase/ decrease in long-term debt (5) 226 Increase/ decrease in short-term 191 106 borrowings and bank overdrafts Cash flow from financing activities 81 270 Net increase/(decrease) in cash and (62) (148) cash equivalents Effect of exchange rates and changes 1 1 in scope Cash and cash equivalents at 360 254 beginning of period Cash and cash equivalents of discontinued operations at end of - - period Cash advance granted to discontinued - - operations Cash and cash equivalents at end of 299 107 period Of which cash and cash equivalents of - - discontinued operations CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (audited) Shares issued Treasury shares Shareholders' Non- equity - controlling Shareholders' (In millions Number Amount Paid-in Retained Translation Number Amount Group interests equity of euros) surplus earnings adjustments share At January 1, 62,877,215 629 977 610 82 (314,034) (16) 2,282 29 2,311 2013 Cash dividend - - (113) - - - - (113) - (113) Issuance of 70,958 - 2 - - - - 2 - 2 share capital Purchase of treasury - - - - - - - - - - shares Cancellation of purchased - - - - - - - - - - treasury shares Grants of treasury - - - (4) - 87,060 4 - - - shares to employees Sale of treasury - - - - - - - - - - shares Share-based - - - 4 - - - 4 - 4 payments Other - - - - - - - - 6 6 Transactions with 70,958 - (111) - - 87,060 4 (107) 6 (101) shareholders Net income - - - 82 - - - 82 1 83 Total income and expense recognized - - - 23 1 - - 24 - 24 directly through equity Comprehensive - - - 105 1 - - 106 1 107 income At June 30, 62,948,173 629 866 715 83 (226,974) (12) 2,281 36 2,317 2013 INFORMATION BY BUSINESS SEGMENT (non audited) 2^nd quarter 2013 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 477 540 602 10 1,629 sales Inter segment 3 26 21 - sales Total sales 480 566 623 10 EBITDA 93 114 84 (18) 273 Depreciation and (25) (29) (23) (1) (78) amortization Recurring operating 68 85 61 (19) 195 income Other income (5) - (4) (4) (13) and expenses Operating 63 85 57 (23) 182 income Equity in income of - - - 1 1 affiliates Intangible assets and property, 18 49 25 7 99 plant and equipment additions Of which recurring 15 22 25 7 69 capex 2^nd quarter 2012 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 572 566 575 6 1,719 sales Inter segment 5 34 21 - sales Total sales 577 600 596 6 EBITDA 109 125 83 (11) 306 Depreciation and (27) (29) (20) (1) (77) amortization Recurring operating 82 96 63 (12) 229 income Other income (25) 3 (2) (1) (25) and expenses Operating 57 99 61 (13) 204 income Equity in income of - - - 3 3 affiliates Intangible assets and property, 33 40 32 4 109 plant and equipment additions Of which recurring 33 26 27 3 89 capex INFORMATION BY BUSINESS SEGMENT (audited) End of June 2013 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 925 1,079 1,164 24 3,192 sales Inter segment 6 52 42 - sales Total sales 931 1,131 1,206 24 EBITDA 163 218 161 (35) 507 Depreciation and (51) (57) (45) (1) (154) amortization Recurring operating 112 161 116 (36) 353 income Other income (7) - (5) (128) (140) and expenses Operating 105 161 111 (164) 213 income Equity in income of - - - 3 3 affiliates Intangible assets and property, 31 85 45 13 174 plant and equipment additions Of which recurring 27 35 44 13 119 capex End of June 2012 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 1,106 1,098 1,126 12 3,342 sales Inter segment 12 66 48 - sales Total sales 1,118 1,164 1,174 12 EBITDA 211 222 156 (30) 559 Depreciation and (53) (56) (40) (1) (150) amortization Recurring operating 158 166 116 (31) 409 income Other income (25) 4 (3) (1) (25) and expenses Operating 133 170 113 (32) 384 income Equity in income of - - - 6 6 affiliates Intangible assets and property, 49 63 60 8 180 plant and equipment additions Of which recurring 49 41 51 7 148 capex Contact: Arkema Investor Relations: Sophie Fouillat, +33 1 49 00 86 37 email@example.com or Jérôme Raphanaud, +33 1 49 00 72 07 firstname.lastname@example.org or Press Relations: Gilles Galinier, +33 1 49 00 70 07 email@example.com
Arkema: 2nd Quarter 2013 Results
Press spacebar to pause and continue. Press esc to stop.